Funding-Novel
Approaches to Drug Discovery for Alzheimer's Disease; April 5,
2011
Agency
Alzheimer's Drug
Discovery Foundation
Description
The Alzheimer's Drug
Discovery Foundation (ADDF) funds drug discovery and development research
programs in the field of Alzheimer's disease, related dementias, and cognitive
aging. ADDF seeks to fill the critical translational funding gap between basic
research and later stage drug development by funding high-risk, early-stage
programs and catalyzing scientists to enter the drug discovery field. In
addition to funding academic programs, ADDF also invests in and creates
early-stage biotechnology companies. ADDF also initiates, sponsors, and
cosponsors conferences to stimulate new ideas and approaches in areas of
interest to the foundation, bringing together physicians, scientists, and
policymakers worldwide.
Closing
Date: Letters of Intent
accepted anytime
Application
Deadlines: April 5,
2011
July 5, 2011
October 5, 2011
Link to Full
Announcement